Insider Selling: Oscar Health (NYSE:OSCR) Insider Sells 23,965 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 23,965 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $397,579.35. Following the sale, the insider owned 477,183 shares of the company’s stock, valued at approximately $7,916,465.97. This represents a 4.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Mario Schlosser also recently made the following trade(s):

• On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14.
• On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00.

Oscar Health Stock Performance

OSCR traded up $0.07 during trading on Thursday, hitting $17.17. The stock had a trading volume of 7,737,399 shares, compared to its average volume of 14,589,062. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. The firm has a market cap of $4.55 billion, a price-to-earnings ratio of -15.33 and a beta of 1.88. The company has a 50 day moving average price of $18.08 and a 200-day moving average price of $16.93.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. During the same period in the prior year, the company posted ($0.22) earnings per share. Oscar Health’s revenue was up 23.2% compared to the same quarter last year. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on OSCR. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and upped their target price for the company from $13.00 to $25.00 in a research report on Tuesday, November 25th. Zacks Research raised Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, Barclays upped their price target on shares of Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a report on Monday, November 10th. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $14.86.

Institutional Trading of Oscar Health

A number of hedge funds have recently made changes to their positions in the company. Hsbc Holdings PLC grew its stake in shares of Oscar Health by 2.7% in the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company’s stock valued at $313,000 after buying an additional 632 shares during the period. Straightline Group LLC grew its stake in Oscar Health by 3.7% in the 2nd quarter. Straightline Group LLC now owns 18,082 shares of the company’s stock valued at $388,000 after purchasing an additional 640 shares during the period. Wealthspire Advisors LLC increased its holdings in Oscar Health by 6.7% during the second quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company’s stock worth $238,000 after buying an additional 700 shares during the last quarter. OneDigital Investment Advisors LLC lifted its stake in Oscar Health by 0.6% in the third quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock valued at $2,617,000 after purchasing an additional 779 shares during the last quarter. Finally, Focus Partners Wealth grew its stake in shares of Oscar Health by 1.4% during the 3rd quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock worth $1,094,000 after acquiring an additional 824 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.